Dr. Conor Hayden, a researcher at ADAPT Research Ireland Centre and Trinity College Dublin, has secured €600,000 from Enterprise Ireland to commercialize the "Ribbon device," a non-invasive respiratory sensor aimed at improving patient outcomes and reducing healthcare costs.
Respiratory compromise often goes undetected, leading to longer hospital stays, higher costs, and increased mortality risk. Currently, no solution exists for continuous, non-invasive monitoring of both respiratory rate and volume. The Ribbon device seeks to change that, enabling early detection and intervention.
Above: Dr. Conor Hayden
"This funding is a major milestone, made possible by my mentors at Trinity and the PrecisionALS team," said Dr. Hayden. "The Ribbon device, born from my PhD research, could transform respiratory monitoring and improve patient care."
Dr. Hayden, an expert in medical device design, previously developed Index-eTap, a hand dexterity assessment tool used in clinical studies. He will lead the project with guidance from Trinity's biomedical engineering and medical faculty, including Professors Bruce Murphy and Dara Meldrum, and clinical specialists Dr. Deirdre Murray and Prof. Ignacio Martin-Loeches.
"This grant enables Dr. Hayden to bring an innovative solution to a critical healthcare challenge," said Dr. Meldrum. Prof. Murphy added, "Conor's work has the potential to eliminate preventable complications from respiratory failure, benefiting patients worldwide."
With Enterprise Ireland's backing, the Ribbon device moves closer to revolutionising respiratory monitoring and enhancing patient care globally.